[1] KO W C, DAVID L P, ANTHANASIA J S, et al. Community-acquired klebsiella pneumoniae bacteremia:global differences in clinical patterns[J]. Emerg Infect Dis,2002,8(2):160-166. [2] 杨秀云, 和建波, 郜俪薇, 等.医院感染病原菌的临床分布特征及耐药性分[J]. 中华医院感染学杂志, 2010,20(9):1313-1315. [3] 贾义军,岳枫. 肺炎克雷伯杆菌对氟喹诺酮类抗生素耐药机制的研究[J]. 医学信息,2013,8(13):77-78. [4] HAN Y, LEE J H. Berberine synergy with amphotericin B against disseminated candidiasis in mice[J].Biol Pharma Bull,2005,28(3): 541-544. [5] QUAN H, CAO Y Y, XU Z, et al. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole[J]. Antimicrob Agents Chemother, 2006,50(3):1096-1099. [6] STERMITZ F R, TAWARA-MATSUDA J, LORENZ P, et al. 5′-Methoxyhydnocarpin-D and pheophorbide A: Berberis species components that potentiate berberine growth inhibition of resistant Staphylococcus aureus[J]. J Nat Prod,2000, 63(8):1146-1149. [7] 肖永红, 沈萍, 魏泽庆. Mohnarin 2011 年度全国细菌耐药监测[J]. 中华医院感染学杂志, 2012, 22(22): 4946-4952. [8] 胡付品, 朱德妹, 汪复,等.2013年中国 CHINET 细菌耐药性监测[J]. 中国感染与化疗志,2014,14(5): 365-374. [9] KONG D X, LI X J, TANG G Y, et al. How many traditional Chinese medicine components have been recognized by modern Western medicine? A chemoinformatic analysis and implications for finding multicomponent drugs[J]. Chem Med Chem,2008,3(2): 233-236. [10] FU H, LIU L G,PENG J P, et al. Transcriptional profile of the Shigella flexneri response to an alkaloid:berberine[J]. FEMS Microbiol Lett,2010,303(2):169-175. [11] XU Y, WANG Y, YAN L, et al. Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: endogenous ROS augmentation[J]. J Proteome Res, 2009, 8 (11): 5296-5304. [12] STERMITZ F R, LORENZ P, TAWARA J N,et al. Synergy in a medicinal plant:antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor[J]. Proc Natl Acad Sci U S A, 2000, 97 (4): 1433-1437. |